Telemedical communication patterns in myasthenia gravis in a remote monitoring study

Technical Summary: Telemedical Communication Patterns in Myasthenia Gravis

Problem Statement
Myasthenia gravis (MG) is a rare autoimmune neuromuscular disorder characterized by fluctuating muscle weakness, requiring frequent clinical oversight to manage treatment and prevent crises. However, access to specialized care is often constrained by logistical barriers, including travel distance, scheduling inflexibility, and limited availability of in-person appointments at integrated Myasthenia Centers (iMZ). Previous analyses of patient inquiries indicate a high demand for timely medical advice, yet current standard care models often lack structured mechanisms for remote interaction between patients and specialists between scheduled visits.

Methodology
This study analyzed telemedical communication patterns within a randomized controlled trial involving 45 MG patients observed over a 12-week period (April–September 2023).

• Study Design: Patients were stratified by sex and Myasthenia Gravis Foundation of America (MGFA) status. The intervention group (N=30) utilized the 'MyaLink' platform, which included a mobile application for patient reporting and a web-based dashboard for specialists. The control group (N=15) received standard of care (routine in-person visits with no structured remote contact).
• Intervention: The intervention group used the app to report Patient-Reported Outcome Measures (PROMs: MG-ADL, MG-QoL15r, SSQ, PASS, HADS, CFS) and transmit data from external devices (Garmin Vivosmart 5 for heart rate, oxygen saturation, and steps; MIR Spirobank Smart One for forced vital capacity; and Single Breath Count Test).
• Communication Protocol: Specialists reviewed data and initiated systematic Telemedical Check-ups (TCUs) at weeks 4 and 8. Between TCUs, patients could initiate contact via chat. All interactions were categorized by topic (medical, technical, organizational) and analyzed quantitatively.
• Data Analysis: Communication patterns were quantified by contact frequency, interaction days, and topic distribution. Statistical comparisons between groups utilized non-parametric tests (Mann-Whitney U, Chi-squared) and effect sizes (Cliff's Delta, Cramér's V).

Key Contributions

• Quantitative Communication Mapping: The study provides a granular breakdown of patient-specialist interaction frequencies and topics in a remote MG monitoring setting, distinguishing between patient-initiated and specialist-initiated contacts.
• Trigger Analysis: It identifies specific data points (PROMs, wearable metrics, spirometry) that prompt specialist intervention, distinguishing between reactive (patient-reported) and proactive (data-driven) care.
• Accessibility Assessment: The study evaluates the perceived accessibility of specialist care, comparing patient satisfaction and contact frequency with non-study physicians between the telemedical and standard care groups.

Results

• Contact Volume: In the intervention group, patients initiated a median of 6 contacts per patient (total 205), while specialists initiated a median of 8 contacts per patient (total 274).
• Topic Distribution:
  • Patient-Initiated: 54.5% of contacts concerned medical issues (primarily MG-related therapy and complaints), followed by technical inquiries (25.3%) and organizational issues (19.1%).
  • Specialist-Initiated: 49.4% of contacts were medical, with 38.4% specifically resulting in medication change recommendations. Technical issues accounted for 40.0% of specialist contacts, largely related to initial setup and data entry reminders.
• Data-Driven Interventions: Specialist-initiated contacts were frequently triggered by remote monitoring data. In 75% of cases where specialists contacted patients based on TCU data, the trigger was solely PROMs or wearable data without preceding patient complaints. Specifically, 54.5% of triggers were PROMs, and 25% were due to deteriorating monitoring data.
• Accessibility and Satisfaction: While contact with physicians outside the study team did not differ significantly between groups, the intervention group reported a statistically significant increase in perceived specialist accessibility by the study's end (100% agreement vs. baseline), whereas the control group showed no such change.
• Clinical Impact: 57.4% of specialist recommendations on medical topics required direct intervention (e.g., medication changes), suggesting a high yield of actionable clinical insights derived from remote monitoring.

Significance and Claims
The paper claims that telemedical solutions using remote monitoring and chat functions address a significant unmet need for timely advice in MG, particularly regarding treatment adjustments. The study demonstrates that structured remote monitoring can uncover clinical changes (via PROMs and device data) that patients may not yet perceive or report, enabling proactive specialist intervention.

The authors conclude that while telemedical support significantly improves the perceived accessibility of specialist care and facilitates frequent, actionable communication, the study does not yet confirm a reduction in disease severity or crisis prevention. They emphasize that future research is required to evaluate the potential of these solutions to prevent symptom worsening and to integrate such telemedical workflows into standard clinical care processes. The authors acknowledge limitations including the small sample size, short duration, and the high initial volume of technical inquiries, noting that these are expected in pilot studies with tailored platforms.